LEPEDDA, Antonio Junior
 Distribuzione geografica
Continente #
NA - Nord America 2.025
EU - Europa 1.212
AS - Asia 574
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
SA - Sud America 7
Totale 3.841
Nazione #
US - Stati Uniti d'America 2.013
UA - Ucraina 513
CN - Cina 465
IT - Italia 228
DE - Germania 177
FI - Finlandia 81
FR - Francia 78
SE - Svezia 52
SG - Singapore 49
GB - Regno Unito 35
TR - Turchia 29
KR - Corea 17
BE - Belgio 15
EU - Europa 13
CA - Canada 11
AU - Australia 8
BR - Brasile 7
DK - Danimarca 7
GR - Grecia 5
CZ - Repubblica Ceca 4
IN - India 3
HR - Croazia 2
IR - Iran 2
JP - Giappone 2
LU - Lussemburgo 2
NL - Olanda 2
RO - Romania 2
RU - Federazione Russa 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.841
Città #
Chandler 559
Jacksonville 322
Princeton 174
Nanjing 133
New York 121
Sassari 116
Ann Arbor 82
Wilmington 79
Dearborn 69
Nanchang 59
Beijing 47
Boardman 44
Changsha 31
Shenyang 31
Hebei 29
Singapore 28
Tianjin 28
Woodbridge 28
Izmir 25
Ashburn 21
Jiaxing 21
Seoul 17
Kunming 16
Brussels 15
Zhengzhou 15
Mountain View 14
Andover 13
Hangzhou 13
Ningbo 13
Villiers-sur-marne 13
Norwalk 12
San Francisco 12
Jinan 11
Toronto 9
Ficarazzi 6
Oristano 6
Auburn Hills 5
Dallas 5
Brno 4
Changchun 4
Guangzhou 4
Helsinki 4
London 4
Pátrai 4
Verona 4
Falls Church 3
Hanover 3
Lanzhou 3
Los Angeles 3
Melbourne 3
Molfetta 3
Rome 3
Taizhou 3
Ardabil 2
Augusta 2
Bangkok 2
Cagliari 2
Canberra 2
Fairfield 2
Luxembourg 2
Paris 2
Qingdao 2
Santa Clara 2
Serramanna 2
Tappahannock 2
Turin 2
Zagreb 2
Adelaide 1
Almere Stad 1
Americo Brasiliense 1
Amsterdam 1
Bratislava 1
Brierley Hill 1
Budapest 1
Buffalo 1
Cedar Knolls 1
Chernihiv 1
Chieti 1
Chisinau 1
Città Di Castello 1
Delhi 1
Denver 1
Douglas 1
Edmonton 1
Fazenda Rio Grande 1
Frankfurt am Main 1
Haifa 1
Harrow 1
Hefei 1
Istanbul 1
Latham 1
Logan 1
Media 1
Mexico City 1
Milan 1
Montréal 1
Munich 1
New Plymouth 1
Potenza 1
Quezon 1
Totale 2.355
Nome #
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 82
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 73
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 72
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 71
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 68
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 67
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 67
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 66
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 65
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 63
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 63
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 63
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 62
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 61
Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth 60
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 58
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 56
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 54
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 53
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 53
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 51
Identification and characterization of biomarkers in atherosclerosis and diabetes. 50
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 50
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 50
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 50
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 50
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 49
Sequence variability of apolipoprotein E gene in Corsico-Sardinian ovines 48
Differential proteomic analysis of human atherosclerotic plaque extracts 48
Apolipoprotein Profiles in Atherosclerotic Disease 47
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 47
Apolipoprotein profiles in atherosclerotic disease 46
Structural analysis of glycosaminoglycans and proteoglycans from fresh porcine aortic valves 46
Role of the small proteoglycan bikunin in human reproduction 46
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 46
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 45
Apolipoprotein Profiles in Atherosclerotic Disease 44
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 44
Protein oxidation in unstable plaque extracts from human carotid segments 43
Proteomic analysis of differential protein expression and post-translational modifications in human atherosclerotic plaques 43
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 43
Influencing chondrogenic differentiation of human mesenchymal stromal cells in scaffolds displaying a structural gradient in pore size 43
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 42
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 42
Tuning Cell Differentiation into a 3D Scaffold Presenting a Pore Shape Gradient for Osteochondral Regeneration 42
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 41
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 41
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 41
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 41
Evidence for a pro-oxidant environment in atherosclerotic plaques from human carotid segments 40
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 40
Apolipoprotein profiles in atherosclerotic disease 40
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 40
Glycosaminoglycan content and distribution in human normal and varicose veins 39
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 39
A Collagen-GAG synthetic extracellular matrix entrapped into PLLA polymeric scaffolds. 39
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 38
Protein sulfhydryl-groups oxidation in stable and unstable human carotid plaques 38
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 37
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 36
Human serum albumin Cys34 oxidative modifications after infiltration in the carotid atherosclerotic plaque 36
Urine bikunin as a marker of renal impairment in Fabry's disease 36
Gradients in pore size enhance the osteogenic differentiation of human mesenchymal stromal cells in three-dimensional scaffolds 36
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 33
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 33
Overview of Current Proteomic Approaches for Discovery of Vascular Biomarkers of Atherosclerosis 33
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 33
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 33
Protein sulfhydryl-group oxidation in stable and unstable human carotid plaques 33
GLYCOSAMINOGLYCAN DIVERSITY IN MARINE SPONGE EXTRACELLULAR MATRIX 32
Glycosaminoglycans and fabry’s disease 32
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 30
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 30
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 30
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 30
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 29
Structural analysis of plasma glycosaminoglycans in patients undergoing carotid endarterectomy 28
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 28
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 28
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 27
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 27
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 26
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 26
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 25
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications 21
Glycosaminoglycan diversity in marine sponge extracellular matrix 20
Morphological and biochemical traits of target marine sponges 20
Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers 18
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 16
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 14
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 11
Molecular and pathobiological insights of bikunin/UTI in cancer 10
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability 9
Urine bikunin and kidney involvement in Fabry disease 9
Totale 3.904
Categoria #
all - tutte 18.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020607 0 5 80 12 90 63 123 9 94 32 97 2
2020/2021604 84 6 93 6 85 13 84 4 110 93 16 10
2021/2022477 53 3 3 11 10 2 25 31 63 34 56 186
2022/2023996 94 82 10 185 112 157 0 122 163 13 40 18
2023/2024359 49 25 7 12 83 76 14 8 9 11 36 29
2024/202532 19 13 0 0 0 0 0 0 0 0 0 0
Totale 3.904